Trial Profile
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Intracranial aneurysm
- Focus Therapeutic Use
- 16 Aug 2023 Planned End Date changed from 1 Dec 2025 to 1 Dec 2026.
- 16 Aug 2023 Planned primary completion date changed from 1 Jun 2024 to 1 Jun 2025.
- 25 Apr 2022 Planned End Date changed from 1 Dec 2023 to 1 Dec 2025.